Association of Vitamin D Levels With Multiple Sclerosis Activity and Progression in Patients Receiving Interferon Beta-1b von Fitzgerald, Kathryn C, Munger, Kassandra L, Köchert, Karl, Arnason, Barry G. W, Comi, Giancarlo, Cook, Stuart, Goodin, Douglas S, Filippi, Massimo, Hartung, Hans-Peter, Jeffery, Douglas R, O’Connor, Paul, Suarez, Gustavo, Sandbrink, Rupert, Kappos, Ludwig, Pohl, Christoph, Ascherio, Alberto

Volltext

Interferon-β corrects massive gene dysregulation in multiple sclerosis: Short-term and long-term effects on immune regulation and neuroprotection von Feng, Xuan, Bao, Riyue, Li, Lei, Deisenhammer, Florian, Arnason, Barry G.W., Reder, Anthony T.

Volltext

Treatment of Infantile Spasms: Emerging Insights From Clinical and Basic Science Perspectives von Stafstrom, Carl E., Arnason, Barry G. W., Baram, Tallie Z., Catania, Anna, Cortez, Miguel A., Glauser, Tracy A., Pranzatelli, Michael R., Riikonen, Raili, Rogawski, Michael A., Shinnar, Shlomo, Swann, John W.

Volltext

250 μg or 500 μg interferon beta-1b versus 20 mg glatiramer acetate in relapsing-remitting multiple sclerosis: a prospective, randomised, multicentre study von O'Connor, Paul, MD, Filippi, Massimo, MD, Arnason, Barry, MD, Comi, Giancarlo, MD, Cook, Stuart, MD, Goodin, Douglas, MD, Hartung, Hans-Peter, MD, Jeffery, Douglas, MD, Kappos, Ludwig, MD, Boateng, Francis, PhD, Filippov, Vitali, PhD, Groth, Maria, MD, Knappertz, Volker, MD, Kraus, Christian, MD, Sandbrink, Rupert, MD, Pohl, Christoph, MD, Bogumil, Timon, MD

Volltext

Terbutaline in myasthenia gravis: A pilot study von Soliven, Betty, Rezania, Kourosh, Gundogdu, Betul, Harding-Clay, Barbara, Oger, Joel, Arnason, Barry G.W

Volltext

Mechanisms of action of adrenocorticotropic hormone and other melanocortins relevant to the clinical management of patients with multiple sclerosis von Arnason, Barry G, Berkovich, Regina, Catania, Anna, Lisak, Robert P, Zaidi, Mone

Volltext

Rapid Immune Responses to a Botulinum Neurotoxin Hc Subunit Vaccine through In Vivo Targeting to Antigen-Presenting Cells von WHITE, David M, PELLETT, Sabine, JENSEN, Mark A, TEPP, William H, JOHNSON, Eric A, ARNASON, Barry G. W

Volltext

Olig1 is expressed in human oligodendrocytes during maturation and regeneration von Othman, Ahmad, Frim, David M., Polak, Paul, Vujicic, Snezana, Arnason, Barry G. W., Boullerne, Anne I.

Volltext

Variability in detection and quantification of interferon β-1b-induced neutralizing antibodies von Hartung, Hans-Peter, Kieseier, Bernd, Goodin, Douglas S, Arnason, Barry Gw, Comi, Giancarlo, Cook, Stuart, Filippi, Massimo, Jeffery, Douglas R, Kappos, Ludwig, Bogumil, Timon, Stemper, Brigitte, Sandbrink, Rupert, Nakada, Yukiko, Nakajima, Haruhiko, Schwenke, Susanne, Lehr, Stephan, Heubach, Jürgen, Pohl, Christoph, Reischl, Joachim

Volltext

Axonal metabolic recovery in multiple sclerosis patients treated with interferon β-1b von Narayanan, Sridar, De Stefano, Nicola, Francis, Gordon S., Arnaoutelis, Rozie, Caramanos, Zografos, Collins, D. Louis, Pelletier, Daniel, Arnason, Barry G. W., Antel, Jack P., Arnold, Douglas L.

Volltext

Long-term experience with interferon beta-1b (Betaferon)in multiple sclerosis von Arnason, Barry G W

Volltext

Anti-S-Nitrosocysteine Antibodies Are a Predictive Marker for Demyelination in Experimental Autoimmune Encephalomyelitis: Implications for Multiple Sclerosis von Boullerne, Anne I, Rodriguez, Jose J, Touil, Tarik, Brochet, Bruno, Schmidt, Stephan, Abrous, Nora D, Le Moal, Michel, Pua, Jeffrey R, Jensen, Mark A, Mayo, Willy, Arnason, Barry G. W, Petry, Klaus G

Volltext

A novel Fcγ receptor ligand augments humoral responses by targeting antigen to Fcγ receptors von Jensen, Mark A., Arnason, Barry G. W., White, David M.

Volltext

IMMUNOLOGIC THERAPY OF MULTIPLE SCLEROSIS von Arnason, MD, Barry G. W

Volltext

Immunoglobulin-like transcript 3, an inhibitor of T cell activation, is reduced on blood monocytes during multiple sclerosis relapses and is induced by interferon beta-1b von Jensen, Mark A, Yanowitch, Rachel N, Reder, Anthony T, White, David M, Arnason, Barry G W

Volltext

A phase 3 trial of extended release oral dalfampridine in multiple sclerosis von Goodman, Andrew D., Brown, Theodore R., Edwards, Keith R., Krupp, Lauren B., Schapiro, Randall T, Cohen, Ron, Marinucci, Lawrence N., Blight, Andrew R.

Volltext

Sustained-release oral fampridine in multiple sclerosis: a randomised, double-blind, controlled trial von Goodman, Andrew D, Prof, Brown, Theodore R, MD, Krupp, Lauren B, MD, Schapiro, Randall T, MD, Schwid, Steven R, MD, Cohen, Ron, MD, Marinucci, Lawrence N, MS, Blight, Andrew R, PhD

Volltext

Interferon-gamma-secreting cells in multiple sclerosis patients treated with interferon beta-1b von Dayal, Amit S, Jensen, Mark A, Lledo, Alberto, Arnason, Barry G.W

Volltext

Incidence and course of depression in multiple sclerosis in the multinational BEYOND trial von Schippling, Sven, O’Connor, Paul, Knappertz, Volker, Pohl, Christoph, Bogumil, Timon, Suarez, Gustavo, Cook, Stuart, Filippi, Massimo, Hartung, Hans-Peter, Comi, Giancarlo, Jeffery, Douglas R., Kappos, Ludwig, Goodin, Douglas S., Arnason, Barry

Volltext

Dose comparison trial of sustained-release fampridine in multiple sclerosis von GOODMAN, A. D, BROWN, T. R, COHEN, J. A, KRUPP, L. B, SCHAPIRO, R, SCHWID, S. R, COHEN, R, MARINUCCI, L. N, BLIGHT, A. R

Volltext